Mircette

Mircette is indicated for ovulation control and utilized to manage unintended pregnancy risk.

Strengths: 0.15/0.02mg

Medicine details

Conditions
Alternative names

Mercilon; Gedarel; Desogen

Therapeutic class

Combined Oral Contraceptive

Pharmacological class

Oestrogen and Progestogen

Precautions and warnings

increased risk of thrombosis; hypertension management; smoking status assessment

Minor side effects

spotting; nausea; headache; breast discomfort

Moderate side effects

weight fluctuation; mood disturbance; libido decrease; skin changes

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Organon

Onset Time

1–2 weeks

Duration

24 hours

Storage instructions

Store at room temperature below 25°C.

Drug interactions

St. John's Wort; Phenobarbital; Phenytoin

Age restrictions

Adult women of reproductive age.

Pregnancy and breastfeeding

Pregnancy: Contraindicated. Breastfeeding: Not recommended.

Contraindications

venous thromboembolism; history of deep vein thrombosis; cerebrovascular disease; severe headache; breast cancer

Serious side effects

thrombosis — requires immediate medical attention; stroke — requires immediate medical attention; cardiovascular events — requires immediate medical attention

Patient summary

Mircette is indicated for ovulation control and utilized to manage unintended pregnancy risk.

Mechanism of action

Combines a progestogen and an oestrogen to provide contraceptive protection through ovulation inhibition and by changing cervical mucus and the endometrium to discourage sperm passage and implantation.

Mircette

Mircette is indicated for ovulation control and utilized to manage unintended pregnancy risk.

Editorial Notes

  • Active ingredient(s): Desogestrel, Ethinylestradiol
  • Listed indication(s): Contraception